Pernix Therapeutics (PTX)
Add to Watchlists Create an AlertPernix Therapeutics Enterprise Value:
155.14M for May 24, 2013Pernix Therapeutics Historical Enterprise Value Data
Pro Data ExportThere is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| May 24, 2013 | 155.14M |
| May 23, 2013 | 151.76M |
| May 22, 2013 | 150.64M |
| May 21, 2013 | 148.01M |
| May 20, 2013 | 149.51M |
| May 17, 2013 | 138.26M |
| May 16, 2013 | 140.14M |
| May 15, 2013 | 144.64M |
| May 14, 2013 | 146.14M |
| May 13, 2013 | 146.14M |
| May 10, 2013 | 144.64M |
| May 9, 2013 | 150.26M |
| May 8, 2013 | 152.14M |
| May 7, 2013 | 152.14M |
| May 6, 2013 | 151.76M |
| May 3, 2013 | 153.26M |
| May 2, 2013 | 149.14M |
| May 1, 2013 | 148.01M |
| April 30, 2013 | 160.01M |
| April 29, 2013 | 148.01M |
| April 26, 2013 | 146.14M |
| April 25, 2013 | 146.89M |
| April 24, 2013 | 140.89M |
| April 23, 2013 | 143.89M |
| April 22, 2013 | 150.26M |
| April 19, 2013 | 145.39M |
| April 18, 2013 | 144.26M |
| April 17, 2013 | 146.51M |
| April 16, 2013 | 153.26M |
| April 15, 2013 | 155.14M |
| April 12, 2013 | 170.88M |
| April 11, 2013 | 183.26M |
| April 10, 2013 | 187.38M |
| April 9, 2013 | 191.88M |
| April 8, 2013 | 191.51M |
| April 5, 2013 | 203.50M |
| April 4, 2013 | 204.63M |
| April 3, 2013 | 205.00M |
| April 2, 2013 | 206.13M |
| April 1, 2013 | 209.50M |
| March 28, 2013 | 207.72M |
| March 27, 2013 | 209.23M |
| March 26, 2013 | 210.74M |
| March 25, 2013 | 210.74M |
| March 22, 2013 | 214.52M |
| March 21, 2013 | 211.50M |
| March 20, 2013 | 220.93M |
| March 19, 2013 | 224.70M |
| March 18, 2013 | 227.72M |
| March 15, 2013 | 256.01M |
About Enterprise Value
Click "Learn More" below to see how YCharts calculates Enterprise Value.
Enterprise Value (EV) is a valuation metric alternative to traditional market capitalization that reflects the market value of an entire business. Like market cap, EV is a measure of what the market believes a company is worth. Enterprise value captures the cost of an entire business, including debt and equity. It is a sum of claims of all preferred shareholders, debt holders, security holders, common equity holders, and minority shareholders - unlike market cap, which only captures the total value of common equity securities.
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Learn More
PTX Enterprise Value Benchmarks
| Companies | |
|---|---|
| Mylan | 18.08B |
| Supernus Pharmaceuticals | 139.56M |
| AVANIR Pharmaceuticals | 437.47M |
PTX Enterprise Value Rankings
| Overall |
57th percentile 3398 of 8009 |
| Sector |
49th percentile 348 of 687 in Healthcare |
| Industry |
47th percentile 36 of 69 in Drug Manufacturers - Specialty & Generic |
PTX Enterprise Value Range, Past 5 Years
| Minimum | -1.653M | Oct 10 2008 |
| Maximum | 301.02M | Jan 2 2013 |
| Average | 121.00M |